Outlook Therapeutics Stock (NASDAQ: OTLK)

Outlook Therapeutics (NASDAQ:OTLK) Stock

OUTLOOK THERAPEUTICS INC

Outlook Therapeutics

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics Inc

RSLS

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

GDHG

Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) has outperformed the market over the past 20 years by 2.09% on an annualized basis producing an average annual return of 10.26%. Currently, Caterpillar has a market capitalization of $152.55 billion. 
Buying $1000 In CAT: If an investor had bought $1000 of CAT stock 20 years ago, it would be worth $7,175.26 today based on a price of $324.35 for CAT at the time of writing.
<h3>Caterpillar's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746747014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

$1000 Invested In Caterpillar 20 Years Ago Would Be Worth This Much Today

Elon Musk and Bill Gates have <a href="https://www.benzinga.com/personal-finance/25/03/44434228/elon-musk-said-bill-gates-would-be-obliterated-for-shorting-tesla-but-short-sellers-just-made-16-2-billion-in-3-months-betting-against-him">never exactly seen eye to eye</a>—and when Gates cast doubt on the future of electric trucks back in 2020, Musk wasn't about to let it slide. He made it a point to publicly respond.
It all started when Gates published a detailed blog post on GatesNotes titled "<a href="https://www.gatesnotes.com/moving-around-in-a-zero-carbon-world">How Do We Move In A Zero Carbon World</a>." In it, he laid out his roadmap for decarbonizing transportation.&nbsp;
Gates acknowledged the growing success of electric vehicles for personal use, pointing out that battery prices had dropped 85% since 2010. He also cheered on legacy automakers like GM and Ford for launching electric pickups, and newer players like Rivian and Bollinger.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
But when it came to heavy-duty vehicles—like 18-wheelers, cargo ships, and passenger jets—Gates didn't see a future for batteries.
"The problem is that batteries are big and heavy," he explained. "The more weight you're trying to move, the more batteries you need to power the vehicle. But the more batteries you use, the more weight you add—and the more power you need."
Even with major improvements in battery tech, Gates argued that electric trucks would probably "never be a practical solution" for long-haul transport. Instead, he backed biofuels and electrofuels for these heavier, energy-intensive applications.
Noticeably, while Gates highlighted several electric truck makers, Tesla's Semi wasn't mentioned at all.
Musk, known for speaking his mind, wasn't having it.
When an X user asked for his take on Gates' comments, Musk replied bluntly: "He has no clue."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Elon Musk saying Bill Gates has "no clue" is like Donald Trump claiming to be a very stable genius. <a href="https://t.co/01zOdaH2ss">https://t.co/01zOdaH2ss</a>
&mdash; Gary Marcus (@GaryMarcus) <a href="https://twitter.com/GaryMarcus/status/1304873012378759168?ref_src=twsrc%5Etfw">September 12, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trending: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
It wasn't just a casual disagreement. The jab reflected a deeper rift between the two billionaires—Gates taking a cautious, research-first stance and Musk betting big on pushing technology past its limits.
Gates' blog went beyond trucks. He explained that while transportation gets a lot of attention in climate discussions, it actually accounts for just 16% of global emissions—less than how we power homes, grow food, and manufacture goods. Still, he stressed the importance of decarbonizing how we move, especially since limiting travel would damage economies and hurt vulnerable communities worldwide.
His solution? Use clean electricity where possible, like personal EVs and city buses, but rely on alternative fuels for everything else. He pointed to promising advancements in biofuels and electrofuels, even though he admitted both were still expensive and underfunded.
But Musk was already all-in on making electric trucks practical. Tesla's Semi was in development, promising to defy the battery weight concerns Gates described.&nbsp;
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
Fast forward to 2023, and the topic came roaring back.
In September, a user on X shared an excerpt from Walter Isaacson's biography of Musk, which covered the long-running feud—including disagreements over EVs, Mars, and Gates' decision to short Tesla stock.
Musk seized the opportunity to <a href="https://x.com/elonmusk/status/1701142930025574703">once again address Gates' electric truck claims</a>.
"Gates also said the Tesla Semi was impossible, even though it was literally being driven all over the country," Musk replied.
He added, "When I asked what battery Wh/kg and truck Wh/mile he was using to reach the conclusion that it's impossible, Gates had no idea, but still stuck with his conclusion."
By then, the Tesla Semi had hit the roads, with early models logging serious mileage and companies like PepsiCo integrating them into commercial fleets.&nbsp;
To be fair, Gates wasn't entirely wrong in 2020—battery weight and range were, and still are, major hurdles for long-haul electric trucks. But Musk's vision? It's proven far more practical than Gates, or many other skeptics, predicted.
So, while Gates took the cautious road, Musk kept his foot on the accelerator. And true to form, he had no problem saying <a href="https://www.benzinga.com/25/02/43880898/im-in-awe-bill-gates-says-elon-musk-is-brilliant-rich-and-influential-but-admits-hes-been-mean-to-me-at-times">exactly what he thought along the way</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.</li>
</ul>
Image: Shutterstock

Personal Finance

Elon Musk Said Bill Gates 'Has No Clue' After Gates Claimed Electric Trucks May 'Never Be Practical' Because They Can't Cover Long Distances

Fox Factory Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXF#NASDAQ">FOXF</a>) affirms FY2025 Adj EPS guidance from $1.60-$2.60 to $1.60-$2.60 vs $1.90 analyst estimate. Affirms FY2025 sales outlook from $1.39 billion-$1.49 billion to $1.39 billion-$1.49 billion vs $1.42 billion estimate.

Guidance

FOXF

Correction: Fox Factory Holding Affirms FY2025 Adj EPS Guidance of $1.60-$2.60 vs $1.90 Est; Affirms FY2025 Sales Guidance of $1.39B-$1.49B vs $1.42B Est

Twin Vee PowerCats Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>), ("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today announced the pricing its underwritten public offering of 750,000 shares of its common stock. Each share of common stock is being sold at a public offering price of $4.00 per share. Total gross proceeds from the offering, before deducting the underwriting discount and other offering expenses, are expected to be $3,000,000. The offering is expected to close on May 12, 2025, subject to satisfaction of customary closing conditions.
The Company intends to use the net proceeds from the offering primarily for working capital and general corporate purposes.
ThinkEquity is acting as the sole book-running manager for the offering.

Offerings

VEEE

Twin Vee Powercats Announces Pricing Of $3M Public Offering Of 750K Shares At A Price Of $4/Share

SolarBank Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUUN#NASDAQ">SUUN</a>) (Cboe CA: SUNN) (FSE: GY2) ("SolarBank" or the "Company")&nbsp;announced today that it has filed a final short form base shelf prospectus (the "Shelf Prospectus") with the securities regulatory authorities in each of the provinces of Canada. The Shelf Prospectus replaces the Company's prior final short form base shelf prospectus dated May 2, 2023 which would have expired in June 2025. A corresponding shelf registration statement on Form F-10 (the "Registration Statement") has been filed with the United States Securities and Exchange Commission but is not yet effective.
The Shelf Prospectus will enable the Company to make offerings of up to C$200 million of common shares, debt securities, warrants, subscription receipts, units and share purchase contracts or a combination thereof of the Company from time to time, separately or together, in amounts, at prices and on terms to be determined based on market conditions at the time of the offering and as set out in an accompanying prospectus supplement, during the 25-month period that the Shelf Prospectus remains valid.

SUUN

SolarBank Corporation Files New C$200 Million Shelf Prospectus In Canada And U.S., Replacing 2023 Version, Pending SEC Approval

Equinix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) has outperformed the market over the past 15 years by 4.19% on an annualized basis producing an average annual return of 15.46%. Currently, Equinix has a market capitalization of $83.80 billion. 
Buying $100 In EQIX: If an investor had bought $100 of EQIX stock 15 years ago, it would be worth $846.76 today based on a price of $860.99 for EQIX at the time of writing.
<h3>Equinix's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746746112_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EQIX

Here's How Much $100 Invested In Equinix 15 Years Ago Would Be Worth Today

Waste Connections (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCN#NYSE">WCN</a>) has outperformed the market over the past 10 years by 9.58% on an annualized basis producing an average annual return of 19.98%. Currently, Waste Connections has a market capitalization of $50.53 billion. 
Buying $1000 In WCN: If an investor had bought $1000 of WCN stock 10 years ago, it would be worth $6,175.58 today based on a price of $195.56 for WCN at the time of writing.
<h3>Waste Connections's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746745218_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Genmab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMAB#NASDAQ">GMAB</a>) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.23 by 34.78 percent. This is a 6.9 percent increase over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $715.00 million which missed the analyst consensus estimate of $748.58 million by 4.49 percent. This is a 19.08 percent increase over sales of $600.43 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

GMAB

Genmab Q1 EPS $0.31 Beats $0.23 Estimate, Sales $715.00M Miss $748.58M Estimate

CeriBell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBLL#NASDAQ">CBLL</a>) raises FY2025 sales outlook from $81.00 million-$85.00 million to $83.00 million-$87.00 million vs $83.72 million estimate.

CBLL

CeriBell Raises FY2025 Sales Guidance from $81.00M-$85.00M to $83.00M-$87.00M vs $83.72M Est

HCI Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCI#NYSE">HCI</a>) reported quarterly earnings of $5.35 per share which beat the analyst consensus estimate of $4.38 by 22.15 percent. This is a 46.58 percent increase over earnings of $3.65 per share from the same period last year. The company reported quarterly sales of $216.43 million which beat the analyst consensus estimate of $214.89 million by 0.72 percent. This is a 4.75 percent increase over sales of $206.61 million the same period last year.

HCI Group Q1 EPS $5.35 Beats $4.38 Estimate, Sales $216.43M Beat $214.89M Estimate

Inseego (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.08) by 100 percent. This is a 63.64 percent increase over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $31.67 million which missed the analyst consensus estimate of $32.06 million by 1.20 percent. This is a 29.63 percent decrease over sales of $45.01 million the same period last year.

INSG

Inseego Q1 EPS $(0.16) Misses $(0.08) Estimate, Sales $31.67M Miss $32.06M Estimate

ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) sees Q2 sales of $108.000 million-$114.000 million vs $114.22 million analyst estimate.

ZipRecruiter Sees Q2 Sales $108.000M-$114.000M vs $114.22M Est

AVITA Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCEL#NASDAQ">RCEL</a>) affirms FY2025 sales outlook from $100.00 million-$106.00 million to $100.00 million-$106.00 million vs $102.26 million estimate.

RCEL

AVITA Medical Affirms FY2025 Commercial Revenue Guidance of $100.00M-$106.00M vs $102.26M Est

Mach Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) reported quarterly earnings of $0.31 per share which missed the analyst consensus estimate of $0.63 by 50.79 percent. This is a 29.55 percent decrease over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $226.77 million which missed the analyst consensus estimate of $254.54 million by 10.91 percent. This is a 5.18 percent decrease over sales of $239.16 million the same period last year.

CORRECTION: Mach Natural Resources Q1 Adj. EPS $0.31 Misses $0.63 Estimate, Sales $226.77M Miss $254.54M Estimate

Varex Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VREX#NASDAQ">VREX</a>) is looking for Q3 Adj EPS of $(0.05)-$0.10 vs $0.16 analyst estimate. sees sales of $180.000 million-$200.000 million vs $210.00 million analyst estimate.

VREX

Varex Imaging Sees Q3 Adj EPS $(0.05)-$0.10 vs $0.16 Est; Sees Sales $180.000M-$200.000M vs $210.00M Est

Shareholders of UnitedHealth Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) filed a class-action lawsuit on Wednesday accusing the company of misleading investors by concealing the negative business impacts that followed the December 2024 killing of UnitedHealthcare <a href="https://www.benzinga.com/news/legal/25/02/43887520/luigi-mangione-back-in-court-friday-supporters-donate-500k-to-suspected-killer">CEO Brian Thompson.</a>
The Details: The lawsuit alleges UnitedHealth withheld critical information regarding the backlash and regulatory scrutiny that arose after the CEO's death, particularly concerning the company's aggressive claims denial practices.&nbsp;
Read Next: <a href="https://www.benzinga.com/general/travel/25/05/45260938/disneys-new-abu-dhabi-theme-park-will-be-authentically-disney-and-distinctly-emirati-ceo-bob-iger-says?utm_source=articleShare">Disney&#8217;s New Abu Dhabi Theme Park Will Be &#8216;Authentically Disney And Distinctly Emirati,&#8217; CEO Bob Iger Says&nbsp;</a>
According to the plaintiffs, the public outcry and scrutiny forced strategic, more "patient-friendly" changes that would reduce the company's profitability.
UnitedHealth had initially forecasted adjusted earnings per share between $29.50 and $30 for 2025 and reaffirmed this outlook in January 2025, despite mounting public and regulatory pressures.&nbsp;
However, on April 17, 2025, the company revised its 2025 profit forecast downward to a range of $26 to $26.50. UnitedHealth stock plunged 22.4%, wiping out approximately $119 billion in market value in one day.&nbsp;
The shareholders contend UnitedHealth's failure to disclose the shift away from its previously aggressive claim denial strategies and the resulting impact on profitability constituted materially false and misleading statements. 
The lawsuit was filed in federal court in Manhattan and named UnitedHealth executives, including CEO Andrew Witty and CFO John Rex, as defendants. It covers the period from Dec. 3, 2024, to April 16, 2025, and seeks damages for shareholders who purchased UnitedHealth shares during that time.
&#8220;The company denies any allegations of wrongdoing and intends to defend the matter vigorously,&#8221; a UnitedHealthcare spokesperson said in a statement to NBC News.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/05/45226604/president-trump-wants-to-reopen-alcatraz-heres-what-it-would-take?utm_source=articleShare">President Trump Wants To Reopen Alcatraz: Here&#8217;s What It Would Take</a></li>
</ul>
Image: Shutterstock

Health Care

Legal

Management

Insurance

General

UnitedHealth Investors Claim Company Hid Profit Impact Of CEO's Murder

Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) has outperformed the market over the past 20 years by 5.21% on an annualized basis producing an average annual return of 13.37%. Currently, Oracle has a market capitalization of $422.43 billion. 
Buying $1000 In ORCL: If an investor had bought $1000 of ORCL stock 20 years ago, it would be worth $12,170.04 today based on a price of $150.64 for ORCL at the time of writing.
<h3>Oracle's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746744319_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ORCL

Here's How Much $1000 Invested In Oracle 20 Years Ago Would Be Worth Today

Press Releases

Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial

Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar

Outlook Therapeutics® Announces Presentation of Efficacy and Safety Results from NORSE EIGHT Clinical Trial Evaluating ONS-5010 for the Treatment of Wet AMD

Comments

Outlook Therapeutics

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL